Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model
- PMID: 17510409
- DOI: 10.1158/0008-5472.CAN-06-4473
Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model
Abstract
Fas ligand (FasL/CD95L), a member of the tumor necrosis factor family, interacts with a specific receptor Fas, ultimately leading to cell death. Tumor expression of FasL has been proposed to aid in immune evasion through a "Fas counterattack" mechanism but has also been described as a proinflammatory factor. Here, we tested the role of FasL in a mouse model of spontaneous tumor development. We used the Min mouse in which multiple benign polyps develop in the intestine due to a mutation in the Apc tumor suppressor gene. Mutant mice deficient in functional FasL, termed gld/gld, were crossed to Min mice to generate tumor-prone animals lacking functional FasL. Comparison of FasL-deficient versus proficient Min mice revealed a significant increase in polyp number in the gld/gld mice. We next assessed immune cell infiltration into adenomas. There was no difference in the number of either lymphocytes or macrophages; however, the number of tumor-infiltrating neutrophils was 3-fold lower in the gld/gld specimens compared with controls. Neutrophil migration in vitro was stimulated by wild-type but not mutant FasL. In a nontumor-bearing colitis model in vivo, neutrophil recruitment to the intestine was also reduced in gld/gld mice. Although the Fas counterattack hypothesis suggests that the absence of FasL would result in increased immune-mediated tumor elimination, the opposite is true in the Min model with lack of functional FasL associated with reduced neutrophil influx and increased tumor development. Thus, the proinflammatory rather than counterattack role of tumor FasL is more relevant.
Similar articles
-
Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.Cancer Res. 2005 Nov 1;65(21):9817-23. doi: 10.1158/0008-5472.CAN-05-1462. Cancer Res. 2005. PMID: 16267003
-
Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.J Immunol. 1999 Jun 15;162(12):7350-7. J Immunol. 1999. PMID: 10358186
-
Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.Cancer Res. 2004 Dec 15;64(24):8876-81. doi: 10.1158/0008-5472.CAN-04-2958. Cancer Res. 2004. PMID: 15604247
-
Manipulation of the mouse germline in the study of Min-induced neoplasia.Semin Cancer Biol. 1996 Oct;7(5):249-60. doi: 10.1006/scbi.1996.0033. Semin Cancer Biol. 1996. PMID: 9110402 Review.
-
Application of the Apc(Min/+) mouse model for studying inflammation-associated intestinal tumor.Biomed Pharmacother. 2015 Apr;71:216-21. doi: 10.1016/j.biopha.2015.02.023. Epub 2015 Feb 24. Biomed Pharmacother. 2015. PMID: 25960239 Review.
Cited by
-
Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.PLoS One. 2010 Feb 5;5(2):e9070. doi: 10.1371/journal.pone.0009070. PLoS One. 2010. PMID: 20140201 Free PMC article.
-
Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth In Vivo.ACS Nano. 2022 Aug 23;16(8):12695-12710. doi: 10.1021/acsnano.2c04420. Epub 2022 Aug 8. ACS Nano. 2022. PMID: 35939651 Free PMC article.
-
Effect of P2 receptor on the intracellular calcium increase by cancer cells in human umbilical vein endothelial cells.Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):429-36. doi: 10.1007/s00210-007-0259-2. Epub 2008 Jan 22. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18210093
-
An apoptosis-independent role of SMAC in tumor suppression.Oncogene. 2013 May 9;32(19):2380-9. doi: 10.1038/onc.2012.265. Epub 2012 Jul 2. Oncogene. 2013. PMID: 22751125 Free PMC article.
-
Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance.Cancer Res. 2012 Sep 15;72(18):4724-32. doi: 10.1158/0008-5472.CAN-12-1347. Epub 2012 Jul 17. Cancer Res. 2012. PMID: 22805310 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous